Here are four quick facts:
1. Orthofix shares have posted positive gains of 17.64 percent in the last four weeks.
2. The counter has underperformed the S&P 500 by 1.13 percent during the past week but Orthofix outperformed the index in four weeks by 18.23 percent.
3. The company has a 52-week high of $42.61 and the 52-week low of the share price is $27.85.
4. The company has a market cap of $744 million.
More articles on devices:
Nexxt Spine develops DT Elite Guide System: 4 things to know
Prosidyan’s synthetic bone graft substitute receives FDA clearance: 4 things to note
Center for Regenerative Orthopedics offers platelet rich plasma therapy for arthritis, overuse injuries — 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
